The results indicated that the model based on six genes, namely,NKX2-1,CD8A,IL2RB,IDO1,SFTA3, andCXCL9, was able to accurately predict NSCLC prognosis and immunotherapy response. This evidence concerns the gene NKX2-1 and non-small cell lung carcinoma.